US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services, Pontifica Universidad Catoclica de Chile on Oct. 7 for "c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same" (Chilean, American Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,047, issued on Oct. 7, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.) and Pontifica Universidad Catoclica de Chile (Santiago, Chile).

"c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same" was invented by Juan J. Marugan (Gaithersburg, Md.), Marc Ferrer (Potomac, Md.), Noel T. Southall (Potomac, Md.), Andres E. Dulcey (Gaithersburg, Md.), Xin Hu (Frederick, Md.), Christopher R. Dextras (Frederick, Md.), Daniel C. Talley (Baltimore), Alejandra Alvarez (Santiago, Chile), Silvana Zanlungo (Santiago, Chile) and Rommy M. Von Bernhardi (Santiago, Chile).

Acco...